269 related articles for article (PubMed ID: 35432770)
1. Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis.
Woodard DA; Kim G; Nilsson KR
World J Cardiol; 2022 Mar; 14(3):177-186. PubMed ID: 35432770
[TBL] [Abstract][Full Text] [Related]
2. Risk Profiles and Outcomes of Patients Receiving Cardiovascular Implantable Electronic Devices With and Without Antibacterial Envelopes.
Woodard DA; Kim G; Nilsson KR
Cureus; 2022 May; 14(5):e24739. PubMed ID: 35686253
[TBL] [Abstract][Full Text] [Related]
3. Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures.
Deering TF; Catanzaro JN; Woodard DA
Front Cardiovasc Med; 2022; 9():1006091. PubMed ID: 36620632
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.
Xiang K; Catanzaro JN; Elayi C; Esquer Garrigos Z; Sohail MR
Cureus; 2021 Feb; 13(2):e13088. PubMed ID: 33728111
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
6. Differences between cardiac implantable electronic device envelopes evaluated in an animal model.
Ip JE; Xu L; Lerman BB
J Cardiovasc Electrophysiol; 2021 May; 32(5):1346-1354. PubMed ID: 33010088
[TBL] [Abstract][Full Text] [Related]
7. Patient Profiles in the Utilization of the CanGaroo® Envelope.
Nayak H; Beaser AD; Aziz ZA
Cureus; 2021 Jan; 13(1):e12702. PubMed ID: 33604224
[TBL] [Abstract][Full Text] [Related]
8. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
Kolek MJ; Dresen WF; Wells QS; Ellis CR
Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
[TBL] [Abstract][Full Text] [Related]
9. Effects of envelopes on cardiac implantable electronic device pocket healing: A head-to-head preclinical evaluation.
Virmani R; Philippon F; Mittal S; Finn A; Kudlik D; Kirchhof N; Lexcen D; Kassotis J
Heart Rhythm; 2024 Mar; ():. PubMed ID: 38555971
[TBL] [Abstract][Full Text] [Related]
10. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
11. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
[TBL] [Abstract][Full Text] [Related]
12. Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients.
Kennergren C
Arrhythm Electrophysiol Rev; 2015 May; 4(1):53-7. PubMed ID: 26835101
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Implantable Electronic Device Infection in Patients at Risk.
Tarakji KG; Ellis CR; Defaye P; Kennergren C
Arrhythm Electrophysiol Rev; 2016 May; 5(1):65-71. PubMed ID: 27403296
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
16. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
[TBL] [Abstract][Full Text] [Related]
17. Device infection in patients undergoing pacemaker or defibrillator surgery: risk stratification using the PADIT score.
de Heide J; van der Graaf M; Holl MJ; Hoogendijk MG; Bhagwandien RE; Wijchers SA; Theuns DAMJ; Szili-Torok T; Zijlstra F; Lenzen MJ; Yap SC
J Interv Card Electrophysiol; 2024 Jan; ():. PubMed ID: 38286881
[TBL] [Abstract][Full Text] [Related]
18. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.
Tarakji KG; Korantzopoulos P; Philippon F; Biffi M; Mittal S; Poole JE; Kennergren C; Lexcen DR; Lande JD; Seshadri S; Wilkoff BL
Heart Rhythm; 2021 Dec; 18(12):2080-2086. PubMed ID: 34280568
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis.
Burnhope E; Rodriguez-Guadarrama Y; Waring M; Guilder A; Malhotra B; Razavi R; Rinaldi CA; Pennington M; Carr-White G
J Med Econ; 2019 May; 22(5):464-470. PubMed ID: 30744444
[TBL] [Abstract][Full Text] [Related]
20. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
